This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

30 May 2012

Bristol-Myers Squibb Announces Global Industry-academia Collaboration

The International Immuno-Oncology Network will work to improve scientists' understanding of ways to harness the immune system to fight cancer.

Bristol-Myers Squibb has announced the formation of a new global collaboration between industry and academic institutions that will work together to advance the field of immuno-oncology.


The International Immuno-Oncology Network (II-ON) aims to discover ways to harness the body's own immune system to fight cancer.


A total of ten leading cancer research institutions in France, Italy, Spain, the UK, The Netherlands and the US make up the network, which hopes to advance innovation in drug discovery and development.


Dr Elliott Sigal, executive vice-president, chief scientific officer and president of research and development at Bristol-Myers Squibb, said: "The International Immuno-Oncology Network

Related News